Vaccine children with poor asthma control to reduce the risk of COVID-19

Research teams at universities in Edinburgh, Aberdeen, Glasgow, Strasclide, St Andrews and Public Health Scotland use anonymized linked patient data to track pandemics and cover 99% of Scotland’s EAVE II project. I analyzed the dataset as part. population.

Using the EAVE II COVID-19 monitoring platform throughout Scotland, anonymized health records of approximately 750,000 people aged 5 to 17 years across Scotland were analyzed, including 63,463 children diagnosed with asthma.

Between March 1, 2020 and July 27, 2021, there were 4,339 confirmed cases of COVID-19 among children with asthma. Of these, 67 children were hospitalized.

Among asthma-free children, there were 40,231 confirmed cases of COVID-19, of which 382 were admitted to the hospital.

Using two or more recent courses of oral steroids as a marker of uncontrolled asthma, 255 per 100,000 children with poor asthma control were hospitalized for COVID-19, compared with 54 per 100,000 children without asthma and 91 per 100,000 children with good asthma control. It was a person...

Of the 100,000 children with asthma who have been hospitalized for asthma in the last two years, 548 have been hospitalized for COVID-19, compared to 94 per 100,000 who have not been hospitalized for asthma in the last two years. was.

The results are published in Lancet Respiratory Medicine..

Therefore, children with poor asthma control should be considered a Covid-19 vaccination priority alongside other high-risk children...

“As with any medical intervention, it is important to consider both the risks and benefits of vaccination. New evidence from children over the age of 5 is that the Covid-19 vaccine is holistic by the majority of children. It suggests that it is well tolerated. A policymaker who decides how to act on these data, ”Professor Azizshake, director of the Asher Institute at the University of Edinburgh and EAVEII research leader.

These data also underscore the importance of maintaining asthma control in children, especially during the COVID-19 pandemic.

The COVID-19 vaccine is already available for children aged 12 to 17 years and we recommend that you consider this option for those who have not yet been vaccinated, especially those who have experienced asthma problems.

Source: Medindia

Back to top button